Feedback / Questions
Cysview (hexaminolevulinate) - Photocure
https://www.prnewswire.com/news-releases/asieris-pharmaceuticals-unveils-2023-annual-report-core-product-apl-1702-succeeds-in-global-phase-iii-clinical-trials-apl-1706-obtains-nda-acceptance-domestically-specialty-commercial-team-generates-sustained-revenue-streams-302119669.html
Apr 17, 2024
SHARE THIS
Print
Email
More sharing
Reddit
StumbleUpon
Delicious
Next